Rosenberg S J, Williams R D
Urol Clin North Am. 1986 Aug;13(3):435-44.
Photodynamic therapy for bladder cancer is an intriguing modality with theoretical potential for successful treatment of visible tumor and areas of carcinoma in situ and dysplasia throughout the bladder mucosa. There remain many unanswered determinations about photodynamic therapy, including the most effective photosensitizer, the dose of laser that should be used, and the optimum timing for laser therapy following the injection of photosensitizer. Nonetheless, clinical studies thus far have shown photodynamic therapy to have efficacy in eradicating superficial noninvasive tumors. Treatment of diffuse carcinoma in situ at present appears the most impressive. Prospective studies designed to examine photodynamic therapy in a standardized protocol in comparison with other conventional methods for treatment and prophylaxis of noninvasive bladder cancer are most needed and are currently in progress. In the future, development of alternate photosensitizers or methods of direct intravesical uptake of DHE, perhaps limiting cutaneous phototoxicity, are expected.
膀胱癌的光动力疗法是一种引人关注的治疗方式,在理论上有成功治疗膀胱黏膜可见肿瘤、原位癌区域和发育异常区域的潜力。关于光动力疗法仍有许多未解答的问题,包括最有效的光敏剂、应使用的激光剂量以及注射光敏剂后进行激光治疗的最佳时机。尽管如此,迄今为止的临床研究表明光动力疗法在根除浅表性非侵袭性肿瘤方面具有疗效。目前,弥漫性原位癌的治疗效果最为显著。最需要开展前瞻性研究,按照标准化方案将光动力疗法与其他治疗和预防非侵袭性膀胱癌的传统方法进行比较,此类研究目前正在进行中。未来,预计会开发出替代光敏剂或直接膀胱内摄取二氢卟吩醚的方法,这或许可以限制皮肤光毒性。